ID   ACSL4_HUMAN             Reviewed;         711 AA.
AC   O60488; D3DUY2; O60848; O60849; Q5JWV8;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 2.
DT   15-MAR-2017, entry version 175.
DE   RecName: Full=Long-chain-fatty-acid--CoA ligase 4;
DE            EC=6.2.1.3;
DE   AltName: Full=Long-chain acyl-CoA synthetase 4;
DE            Short=LACS 4;
GN   Name=ACSL4; Synonyms=ACS4, FACL4, LACS4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RX   PubMed=9598324; DOI=10.1006/geno.1998.5268;
RA   Cao Y., Traer E., Zimmerman G.A., McIntyre T.M., Prescott S.M.;
RT   "Cloning, expression, and chromosomal localization of human long-chain
RT   fatty acid-CoA ligase 4 (FACL4).";
RL   Genomics 49:327-330(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT), AND INVOLVEMENT
RP   IN ATS-MR.
RC   TISSUE=Placenta, and Retina;
RX   PubMed=9480748; DOI=10.1006/geno.1997.5104;
RA   Piccini M., Vitelli F., Bruttini M., Pober B.R., Jonsson J.J.,
RA   Villanova M., Zollo M., Borsani G., Ballabio A., Renieri A.;
RT   "FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is
RT   deleted in a family with Alport syndrome, elliptocytosis, and mental
RT   retardation.";
RL   Genomics 47:350-358(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SHORT).
RC   TISSUE=Stomach;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SHORT).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-447, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   VARIANT MRX63 SER-570.
RX   PubMed=11889465; DOI=10.1038/ng857;
RA   Meloni I., Muscettola M., Raynaud M., Longo I., Bruttini M.,
RA   Moizard M.-P., Gomot M., Chelly J., des Portes V., Fryns J.-P.,
RA   Ropers H.-H., Magi B., Bellan C., Volpi N., Yntema H.G., Lewis S.E.,
RA   Schaffer J.E., Renieri A.;
RT   "FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-
RT   linked mental retardation.";
RL   Nat. Genet. 30:436-440(2002).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] CYS-133.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Activation of long-chain fatty acids for both synthesis
CC       of cellular lipids, and degradation via beta-oxidation.
CC       Preferentially uses arachidonate and eicosapentaenoate as
CC       substrates.
CC   -!- CATALYTIC ACTIVITY: ATP + a long-chain fatty acid + CoA = AMP +
CC       diphosphate + an acyl-CoA.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250};
CC       Single-pass type III membrane protein {ECO:0000250}. Peroxisome
CC       membrane {ECO:0000250}; Single-pass type III membrane protein
CC       {ECO:0000250}. Microsome membrane {ECO:0000250}; Single-pass type
CC       III membrane protein {ECO:0000250}. Endoplasmic reticulum membrane
CC       {ECO:0000250}; Single-pass type III membrane protein
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=O60488-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=O60488-2; Sequence=VSP_000238;
CC   -!- DISEASE: Mental retardation, X-linked 63 (MRX63) [MIM:300387]: A
CC       disorder characterized by significantly below average general
CC       intellectual functioning associated with impairments in adaptive
CC       behavior and manifested during the developmental period.
CC       Intellectual deficiency is the only primary symptom of non-
CC       syndromic X-linked mental retardation, while syndromic mental
CC       retardation presents with associated physical, neurological and/or
CC       psychiatric manifestations. {ECO:0000269|PubMed:11889465}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Alport syndrome with mental retardation, midface
CC       hypoplasia and elliptocytosis (ATS-MR) [MIM:300194]: A X-linked
CC       contiguous gene deletion syndrome characterized by
CC       glomerulonephritis, sensorineural hearing loss, mental
CC       retardation, midface hypoplasia and elliptocytosis.
CC       {ECO:0000269|PubMed:9480748}. Note=The gene represented in this
CC       entry may be involved in disease pathogenesis.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF030555; AAC17493.1; -; mRNA.
DR   EMBL; Y12777; CAA73314.1; -; mRNA.
DR   EMBL; Y13058; CAA73501.1; -; mRNA.
DR   EMBL; AK292070; BAF84759.1; -; mRNA.
DR   EMBL; CH471120; EAX02671.1; -; Genomic_DNA.
DR   EMBL; CH471120; EAX02672.1; -; Genomic_DNA.
DR   EMBL; CH471120; EAX02673.1; -; Genomic_DNA.
DR   EMBL; CH471120; EAX02674.1; -; Genomic_DNA.
DR   EMBL; BC034959; AAH34959.1; -; mRNA.
DR   CCDS; CCDS14548.1; -. [O60488-1]
DR   CCDS; CCDS14549.1; -. [O60488-2]
DR   RefSeq; NP_001305438.1; NM_001318509.1. [O60488-1]
DR   RefSeq; NP_001305439.1; NM_001318510.1. [O60488-2]
DR   RefSeq; NP_004449.1; NM_004458.2. [O60488-2]
DR   RefSeq; NP_075266.1; NM_022977.2. [O60488-1]
DR   RefSeq; XP_005262166.1; XM_005262109.2. [O60488-1]
DR   RefSeq; XP_006724698.1; XM_006724635.2. [O60488-2]
DR   RefSeq; XP_011529190.1; XM_011530888.2. [O60488-1]
DR   RefSeq; XP_011529191.1; XM_011530889.2. [O60488-1]
DR   UniGene; Hs.268785; -.
DR   ProteinModelPortal; O60488; -.
DR   BioGrid; 108478; 40.
DR   IntAct; O60488; 21.
DR   MINT; MINT-3000036; -.
DR   STRING; 9606.ENSP00000339787; -.
DR   DrugBank; DB00159; Icosapent.
DR   DrugBank; DB00412; Rosiglitazone.
DR   DrugBank; DB00197; Troglitazone.
DR   SwissLipids; SLP:000000201; -.
DR   SwissLipids; SLP:000000515; -. [O60488-1]
DR   SwissLipids; SLP:000000516; -. [O60488-2]
DR   iPTMnet; O60488; -.
DR   PhosphoSitePlus; O60488; -.
DR   SwissPalm; O60488; -.
DR   BioMuta; ACSL4; -.
DR   EPD; O60488; -.
DR   MaxQB; O60488; -.
DR   PaxDb; O60488; -.
DR   PeptideAtlas; O60488; -.
DR   PRIDE; O60488; -.
DR   DNASU; 2182; -.
DR   Ensembl; ENST00000340800; ENSP00000339787; ENSG00000068366. [O60488-1]
DR   Ensembl; ENST00000348502; ENSP00000262835; ENSG00000068366. [O60488-2]
DR   Ensembl; ENST00000469796; ENSP00000419171; ENSG00000068366. [O60488-1]
DR   GeneID; 2182; -.
DR   KEGG; hsa:2182; -.
DR   UCSC; uc004eoi.3; human. [O60488-1]
DR   CTD; 2182; -.
DR   DisGeNET; 2182; -.
DR   GeneCards; ACSL4; -.
DR   HGNC; HGNC:3571; ACSL4.
DR   HPA; HPA000286; -.
DR   HPA; HPA005552; -.
DR   MalaCards; ACSL4; -.
DR   MIM; 300157; gene.
DR   MIM; 300194; phenotype.
DR   MIM; 300387; phenotype.
DR   neXtProt; NX_O60488; -.
DR   OpenTargets; ENSG00000068366; -.
DR   Orphanet; 86818; Alport syndrome - intellectual disability - midface hypoplasia - elliptocytosis.
DR   Orphanet; 777; X-linked non-syndromic intellectual disability.
DR   PharmGKB; PA27968; -.
DR   eggNOG; KOG1256; Eukaryota.
DR   eggNOG; COG1022; LUCA.
DR   GeneTree; ENSGT00870000136474; -.
DR   HOGENOM; HOG000159459; -.
DR   HOVERGEN; HBG106947; -.
DR   InParanoid; O60488; -.
DR   KO; K01897; -.
DR   OMA; RRVNNFG; -.
DR   OrthoDB; EOG091G02F4; -.
DR   PhylomeDB; O60488; -.
DR   TreeFam; TF314012; -.
DR   BioCyc; MetaCyc:HS00935-MONOMER; -.
DR   BRENDA; 6.2.1.15; 2681.
DR   BRENDA; 6.2.1.3; 2681.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   ChiTaRS; ACSL4; human.
DR   GeneWiki; ACSL4; -.
DR   GenomeRNAi; 2182; -.
DR   PRO; PR:O60488; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000068366; -.
DR   CleanEx; HS_ACSL4; -.
DR   ExpressionAtlas; O60488; baseline and differential.
DR   Genevisible; O60488; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0044233; C:ER-mitochondrion membrane contact site; IDA:MGI.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005811; C:lipid particle; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005778; C:peroxisomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0047676; F:arachidonate-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0102391; F:decanoate--CoA ligase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0031957; F:very long-chain fatty acid-CoA ligase activity; IMP:UniProtKB.
DR   GO; GO:0060996; P:dendritic spine development; IEA:Ensembl.
DR   GO; GO:0060136; P:embryonic process involved in female pregnancy; IEA:Ensembl.
DR   GO; GO:0015908; P:fatty acid transport; IEA:Ensembl.
DR   GO; GO:0008610; P:lipid biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; IDA:UniProtKB.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0032307; P:negative regulation of prostaglandin secretion; IDA:UniProtKB.
DR   GO; GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB.
DR   GO; GO:0070672; P:response to interleukin-15; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0006641; P:triglyceride metabolic process; IEA:Ensembl.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   Pfam; PF00501; AMP-binding; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   1: Evidence at protein level;
KW   Alport syndrome; Alternative splicing; ATP-binding; Complete proteome;
KW   Deafness; Disease mutation; Elliptocytosis; Endoplasmic reticulum;
KW   Fatty acid metabolism; Hereditary hemolytic anemia; Ligase;
KW   Lipid metabolism; Magnesium; Membrane; Mental retardation; Microsome;
KW   Mitochondrion; Mitochondrion outer membrane; Nucleotide-binding;
KW   Peroxisome; Phosphoprotein; Polymorphism; Reference proteome;
KW   Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN         1    711       Long-chain-fatty-acid--CoA ligase 4.
FT                                /FTId=PRO_0000193109.
FT   TRANSMEM      8     28       Helical; Signal-anchor for type III
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     29    711       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     447    447       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     41       Missing (in isoform Short).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9480748,
FT                                ECO:0000303|PubMed:9598324}.
FT                                /FTId=VSP_000238.
FT   VARIANT     133    133       R -> C (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs753267653).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036376.
FT   VARIANT     570    570       R -> S (in MRX63; dbSNP:rs122458138).
FT                                {ECO:0000269|PubMed:11889465}.
FT                                /FTId=VAR_013180.
FT   CONFLICT    181    181       Y -> C (in Ref. 2; CAA73314).
FT                                {ECO:0000305}.
SQ   SEQUENCE   711 AA;  79188 MW;  6483CD17FE78FE73 CRC64;
     MKLKLNVLTI ILLPVHLLIT IYSALIFIPW YFLTNAKKKN AMAKRIKAKP TSDKPGSPYR
     SVTHFDSLAV IDIPGADTLD KLFDHAVSKF GKKDSLGTRE ILSEENEMQP NGKVFKKLIL
     GNYKWMNYLE VNRRVNNFGS GLTALGLKPK NTIAIFCETR AEWMIAAQTC FKYNFPLVTL
     YATLGKEAVV HGLNESEASY LITSVELLES KLKTALLDIS CVKHIIYVDN KAINKAEYPE
     GFEIHSMQSV EELGSNPENL GIPPSRPTPS DMAIVMYTSG STGRPKGVMM HHSNLIAGMT
     GQCERIPGLG PKDTYIGYLP LAHVLELTAE ISCFTYGCRI GYSSPLTLSD QSSKIKKGSK
     GDCTVLKPTL MAAVPEIMDR IYKNVMSKVQ EMNYIQKTLF KIGYDYKLEQ IKKGYDAPLC
     NLLLFKKVKA LLGGNVRMML SGGAPLSPQT HRFMNVCFCC PIGQGYGLTE SCGAGTVTEV
     TDYTTGRVGA PLICCEIKLK DWQEGGYTIN DKPNPRGEIV IGGQNISMGY FKNEEKTAED
     YSVDENGQRW FCTGDIGEFH PDGCLQIIDR KKDLVKLQAG EYVSLGKVEA ALKNCPLIDN
     ICAFAKSDQS YVISFVVPNQ KRLTLLAQQK GVEGTWVDIC NNPAMEAEIL KEIREAANAM
     KLERFEIPIK VRLSPEPWTP ETGLVTDAFK LKRKELRNHY LKDIERMYGG K
//
